NCT05317611View on ClinicalTrials.gov

Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

January 15, 2025

Study Completion Date

January 26, 2025

Conditions
Prevention
Interventions
DRUG

Intraperitoneal instillation of ondansetron and bupivacaine

The aim is to detect the effect of intraperitoneal instillation of ondansetron for prevention of postoperative nausea and vomiting

DRUG

Intravenous ondansetron and intraperitoneal instillation of bupivacaine

The aim is to detect effect of intravenous ondansetron for prevention of postoperative nausea and vomiting

DRUG

Intraperitoneal instillation of bupivacaine

The aim is to detect effect of intraperitoneal instillation of bupivacaine

Trial Locations (1)

Unknown

faculty of human medicine, Zagazig university hospitals, El Sharkia

All Listed Sponsors
lead

Zagazig University

OTHER_GOV